பார்வை குறைபாடு மற்றும் குருட்டுத்தன்மை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பார்வை குறைபாடு மற்றும் குருட்டுத்தன்மை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பார்வை குறைபாடு மற்றும் குருட்டுத்தன்மை Today - Breaking & Trending Today

ForSight Robotics Raises $10 Million from Eclipse Ventures and Mithril Capital in Seed Round


Press release content from Business Wire. The AP news staff was not involved in its creation.
ForSight Robotics Raises $10 Million from Eclipse Ventures and Mithril Capital in Seed Round
March 11, 2021 GMT
ForSight Robotics is developing a next-generation miniature robotic system to help democratize ophthalmic surgery worldwide. Pictured above is a component of the robot prototype. (Photo: Business Wire)
ForSight Robotics is developing a next-generation miniature robotic system to help democratize ophthalmic surgery worldwide. Pictured above is a component of the robot prototype. (Photo: Business Wire)
YOKENEAM, Israel (BUSINESS WIRE) Mar 11, 2021
ForSight Robotics today announced the company is developing a surgical robotic platform that will transform the future of ophthalmic surgery with a $10 million seed round led by Eclipse Ventures and joined by Mithril Capital. ....

United Kingdom , Elizabeth Yeu , Joseph Nathan , Seth Winterroth , Ajay Royan , Rony Abovitz , Moshe Shoham , Boris Malyugin , Daniel Glozman , Sam Garg , Peter Thiel , Andrew Lavin , Vance Thompson , David Chang , Forsight Robotics Ltd , A Lavin Communications , Mako Surgical Inc , Magic Leap Inc , Technion Israel Institute Of Technology , Ventures For The Alfred Mann Institute , Intuitive Surgical Inc , Us National Academy Of Engineering , Israel Innovation Authority Companies Incentive Program , Forsight Robotics Co , Auris Health Inc , Forsight Co ,

Masimo Monitoring Solutions Promote Newborn and Maternal Safety


Press release content from Business Wire. The AP news staff was not involved in its creation.
Masimo Monitoring Solutions Promote Newborn and Maternal Safety
March 8, 2021 GMT
Masimo Newborn Sensor (Photo: Masimo)
NEUCHATEL, Switzerland (BUSINESS WIRE) Mar 8, 2021
Masimo (NASDAQ: MASI) provides a variety of innovative monitoring solutions designed to improve maternal and newborn safety during childbirth and the critical first minutes of life. Masimo SET ® pulse oximetry’s ability to measure during motion and low perfusion has helped newborns, neonates, and pediatric patients like no other pulse oximetry. Not only has Masimo SET ® helped clinicians reduce retinopathy of prematurity (ROP) 1 and improve screening for critical congenital heart disease (CCHD), 2-10 but it has helped push the standard of care for babies to new heights the evidence from CCHD studies with SET ®, for example, has been used in the establishment of screening guidelines used around t ....

United States , United Kingdom , Asrat Dibaba Tolossa , Marcelo Cardetti , Katsuyuki Miyasaka , Joe Kiani , Masimo Safetynet , Masimo Rad , Mark Ansermino , Hernando Baquero , Sergio Golombek , Department Of Anesthesiology , University Of British Columbia , Child Health Program , Party For The Global Affairs Canada , International Women Day , American Society Of Neonatology , Maternity Of The Center , Nutrition Services To Improve Maternal , Us Department Of Health , Human Services , International Child Health , Screening Panel , Wayo Women University Graduate School , Exchange Commission , University Healthsystem Consortium ,

Foundation Fighting Blindness To Jointly Host Online Continuing Medical Education (CME, COPE) Webinar


Press release content from PR Newswire. The AP news staff was not involved in its creation.
Foundation Fighting Blindness To Jointly Host Online Continuing Medical Education (CME, COPE) Webinar
March 2, 2021 GMT
(PRNewsfoto/Foundation Fighting Blindness)
COLUMBIA, Md., March 2, 2021 /PRNewswire/ The Foundation Fighting Blindness, the world’s leading private funding source for retinal degenerative disease research, will host an online continuing medical education (CME and COPE) course on Monday, April 5, 2021, at 7:00 p.m. Eastern Time.
More than 40 clinical trials for emerging retinal degenerative disease therapies are underway. The studies provide hope for patients and the opportunity for them to participate in the research. ....

United States , University Of Iowa , Alan Kimura , Gerald Fishman , Chris Adams , Benjamin Yerxa , Accreditation Council For Continuing Medical Education , Chicago Medical School , Organization Contact , National Teaching Faculty , Foundation Fighting Blindness , Pascale Communications , University Of Illinois , Marketing Communications , Johns Hopkins Bloomberg School Of Public Health , Medicare Innovation Center , Colorado Retina , Rocky Mountain , Johns Hopkins Bloomberg School , National Teaching , Accreditation Council , Continuing Medical Education , Foundation Fighting , Internet Explorer , Corporate News , Diseases And Conditions ,

GenSight Biologics Announces Publication of Results from LUMEVOQ® Phase I/IIa Clinical Trial REVEAL in BioDrugs


Press release content from Business Wire. The AP news staff was not involved in its creation.
GenSight Biologics Announces Publication of Results from LUMEVOQ® Phase I/IIa Clinical Trial REVEAL in BioDrugs
February 15, 2021 GMT
Regulatory News:
GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today announced that the journal
BioDrugs has published results from REVEAL, the Phase I/IIa clinical trial that evaluated the safety of LUMEVOQ ® gene therapy in subjects with
ND4 Leber Hereditary Optic Neuropathy (LHON) and determined the dose subsequently used in the Phase III trials RESCUE and REVERSE. ....

United States , France General , United Kingdom , Lise Plaine , Magali Taiel , Catherine Vignal , James Palmer , Catherine Vignal Clermont , Marion Janic , Guillaume Van Renterghem , Fondation Ophtalmologique , Gensight Biologics , Denis Oshaughnessy , Thomas Gidoin , Centre Hospitalier National , University Of Pittsburgh Medical Center , University Of Pittsburgh School Medicine , Drug Administration , Rothschild Foundation Hospital , Department Of Neuro Ophthalmology , European Union , European Medicines Agency , Department Of Ophthalmology , Sight Biologics , Hereditary Optic Neuropathy , Leber Hereditary Optic Neuropathy ,